Abstract
Primary dysmenorrhea is a widespread problem in women's health care and has a societal impact in loss of work and school days, and a personal impact on women experiencing monthly pain. Oral contraceptives have frequently been used to prevent dysmenorrhea in recent years. This article reviews current theories regarding the etiology of dysmenorrhea and evaluates use of the combined pill solely for dysmenorrhea in light of the recent approval of antiprostaglandin agents for therapeutic use in relieving menstrual pain.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
